Microfabricated platforms to quantitatively investigate cellular behavior under the influence of chemical gradients

M Elitas, S Sadeghi, H Karamahmutoglu… - Biomedical Physics …, 2017 - iopscience.iop.org
Understanding cellular behavior in a quantitative manner will provide valuable information
to reveal the mechanism of diseases and immune defense and for the discovery of new …

Fluidic device for generating pharmacokinetic profiles matching preset parameters

B LaPorte, FM Musteata - Journal of Pharmaceutical Innovation, 2015 - Springer
Purpose The experimental objective of this research was to develop and validate a
mechanical device that can generate lifelike fluidic pharmacokinetic (PK) profiles for any …

[PDF][PDF] Modified Pharmacokinetic/Pharmacodynamic model for electrically activated silver-titanium implant system

Z Tan, PE Orndorff, RA Shirwaiker - Biomater Biomech Bioeng, 2015 - scholar.archive.org
Silver-based systems activated by low intensity direct current continue to be investigated as
an alternative antimicrobial for infection prophylaxis and treatment. However there has been …

[图书][B] Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation in the Development of Spectinamides, a Novel Class of Anti-Tuberculosis Agents

C Rathi - 2017 - search.proquest.com
New chemotherapeutic agents are urgently needed to control the spread of multidrug-
resistant (MDR) and extensively drug-resistant (XDR) forms of tuberculosis, which still …

Tanjore S. Balganesh, Jagadeesh J. Bhat, and Bheemarao Ugarkar

TS Balganesh - Drug Discovery and Drug Development: The …, 2021 - books.google.com
India has the task of eliminating tuberculosis (TB) by 2025. This translates to curing about
two million TB cases present today as well as reducing the TB infection rates rapidly (WHO …

Pharmacodynamic Evaluation: Infectious Diseases

S Bhuyan, S Felgner, D Kocijancic, V Pawar - Drug Discovery and …, 2020 - Springer
The past decades have witnessed an rise in the number of multidrug resistant bacteria,
concurrent drug failures, and declining cure rates of several fatal bacterial infectious …

[PDF][PDF] Diagnostic value of an IFN-gamma ELISPOT assay to detect latent tuberculosis infection in hepatitis C patients

KS Shen, KY Zhang, F Wang, L Yu… - Afr J Microbiol …, 2012 - academicjournals.org
The rapid diagnosis of tuberculosis (TB) and latent tuberculosis infections (LTBI) is a
significant problem in clinical practice. The aim of this study was to evaluate the diagnostic …

In Vitro and In Silico Approaches to Evaluate the Pharmacokinetics and Pharmacodynamics of Combination Antibiotic Therapy against Drug-Resistant Bacteria

S Das - 2021 - search.proquest.com
This thesis focuses on combating antibacterial resistance by developing novel in vitro and in
silico techniques. In vitro techniques such as in vitro pharmacodynamic (IVPD) modeling are …

[PDF][PDF] Development of a model to characterize the effect of Phela on selected immune markers in immune-suppressed rats

A Walubo - 2015 - scholar.ufs.ac.za
The therapeutic potential of several plant species and necessity for scientific validation of the
use of plant derived medicines has prompted interest in field of traditional medicines …

Pharmacokinetics and Pharmacodynamics of the Tuberculosis Drugs

AB Barth, EF Egelund, CA Peloquin - Antibiotic Pharmacodynamics, 2016 - Springer
In the last 40 years, only rifapentine and bedaquiline have been approved in the USA for the
treatment of active tuberculosis. Therefore, one focus of research involves optimizing the …